Sonoma Biotherapeutics Inc., a clinical-stage biotechnology company, said Monday that Lisa Taylor Ash has been named its chief legal officer and secretary.
In her new role, Ash will help strengthen the company’s strategic and legal operations as it continues to develop its engineered regulatory T-cell therapies for autoimmune and inflammatory diseases, the company said in a news release.
Ash most recently served as chief operating officer and general counsel of Shape Therapeutics. Formerly she was a health care associate at Sidley Austin LLP. Ash sits on the board of Fauna Bio. She earned her JD from Harvard Law School. ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.